The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
MicroRNAs as a therapeutic target for cardiovascular diseases
Abstract
Introduction Biogenesis of miRNAs and their regulatory mechanisms MiRNAs in cardiovascular diseases MiRNAs in hypertrophy MiRNAs in cardiac fibrosis MiRNAs in arrhythmia MiRNAs in myocardial infarction MiRNAs in heart failure MiRNAs in angiogenesis MiRNAs in cardiomyopathy MiRNAs in antherogenesis Role of Dicer in cardiomyopathy MiRNAs ‐ a new strategy for treatment of cardiovascular diseases Therapeutic challenges and their remedies Approaches of miRNAs in cardiovascular therapy MicroRNAs (miRNAs) are tiny, endogenous, conserved, non‐coding RNAs that negatively modulate gene expression by either promoting the degradation of mRNA or down‐regulating the protein production by translational repression. They maintain optimal dose of cellular proteins and thus play a crucial role in the regulation of biological functions. Recent discovery of miRNAs in the heart and their differential expressions in pathological conditions provide glimpses of undiscovered regulatory mechanisms underlying cardiovascular diseases. Nearly 50 miRNAs are overexpressed in mouse heart. The implication of several miRNAs in cardiovascular diseases has been well documented such as miRNA‐1 in arrhythmia, miRNA‐29 in cardiac fibrosis, miRNA‐126 in angiogenesis and miRNA‐133 in cardiac hypertrophy. Aberrant expression of Dicer (an enzyme required for maturation of all miRNAs) during heart failure indicates its direct involvement in the regulation of cardiac diseases. MiRNAs and Dicer provide a particular layer of network of precise gene regulation in heart and vascular tissues in a spatiotemporal manner suggesting their implications as a powerful intervention tool for therapy. The combined strategy of manipulating miRNAs in stem cells for their target directed differentiation and optimizing the mode of delivery of miRNAs to the desired cells would determine the future potential of miRNAs to treat a disease. This review embodies the recent progress made in microRNomics of cardiovascular diseases and the future of miRNAs as a potential therapeutic target ‐ the putative challenges and the approaches to deal with it.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the heart, miRNAs are involved both in cardiogenesis (14, 15) and in disease including: diabetic cardiomyopathy, hypertrophy, ischemia, and electrical remodeling (16-22).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
Wightman, B., Ha, I., & Ruvkun, G. (1993) · Cell · doi:10.1016/0092-8674(93)90530-4 · Cited by 4,292
Widespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429 · cited 1×
“Here, it is germane to mention that a given miRNA is specific of a sequence and not of a single mRNA, and this is the reason that a single miRNA can modify expression of several mRNAs [9].”
BackgroundA pancreatic islet-specific microRNA regulates insulin secretion
Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., MacDonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., et al. (2004) · Nature · doi:10.1038/nature03076 · Cited by 2,102 · cited 1×
“The pancreatic -cells that produce insulin are regulated by miRNAs [62, 63] and particularly miR375 that regulates insulin secretion negatively by targeting myotrophin [62].”
BackgroundMicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866
Intronic microRNA precursors that bypass Drosha processing
Ruby, J. G., Jan, C. H., & Bartel, D. P. (2007) · Nature · doi:10.1038/nature05983 · Cited by 1,722
Tili, E., Michaille, J.-J., Cimino, A., Costinean, S., Dumitru, C. D., Adair, B., Fabbri, M., Alder, H., Liu, C. G., Calin, G. A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5082 · Cited by 1,304 · cited 1×
“The association of miR-155 in regulation of angiotensin II type 1 receptor 1166 A/C polymorphism [73], inflammatory response [74] and endotoxin shock [75] makes it a very promising therapeutic candidate for inflammatory diseases.”
BackgroundPhylogenetic Shadowing and Computational Identification of Human microRNA Genes
Berezikov, E., Guryev, V., van de Belt, J., Wienholds, E., Plasterk, R. H. A., & Cuppen, E. (2005) · Cell · doi:10.1016/j.cell.2004.12.031 · Cited by 1,270 · cited 1×
“In the human genome nearly thousands of unique miRNAs are encoded, and they are predicted to regulate expressions of at least 30% of all human protein encoding genes thereby regulating almost all cellular functions [7, 8].”
BackgroundDevelopment of a self-inactivating lentivirus vector
Miyoshi, H., Blömer, U., Takahashi, M., Gage, F. H., & Verma, I. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8150-8157.1998 · Cited by 1,196
Role of microRNAs in vascular diseases, inflammation, and angiogenesis
Urbich, C., Kuehbacher, A., & Dimmeler, S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn156 · Cited by 880
Research works printed but not linked: 108
- 10.1016/j.cell.2007.08.010 · DOI · Paper page
- 10.1101/gr.4560905 · DOI
- 10.1586/14737159.4.5.609 · DOI
- 10.1161/CIRCRESAHA.107.163147 · DOI · Paper page
- 10.1152/physiolgenomics.00034.2008 · DOI · Paper page
- 10.1038/ng865 · DOI · Paper page
- 10.1016/j.cell.2004.12.035 · DOI · Paper page
- 10.1038/nature03315 · DOI · Paper page
- 10.1016/j.devcel.2008.07.002 · DOI · Paper page
- 10.1126/science.1139089 · DOI · Paper page
- 10.2353/ajpath.2007.061170 · DOI · Paper page
- 10.1128/MCB.01222-08 · DOI · Paper page
- 10.1016/j.yjmcc.2007.04.004 · DOI · Paper page
- 10.1073/pnas.0809579106 · DOI · Paper page
- 10.1002/jcp.21689 · DOI · Paper page
- 10.1073/pnas.0811073106 · DOI · Paper page
- 10.1126/science.1132292 · DOI · Paper page
- 10.1172/JCI33099 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.107.187998 · DOI · Paper page
- 10.1038/nsmb1167 · DOI · Paper page
- 10.1101/gad.1158803 · DOI · Paper page
- 10.1042/CS20070211 · DOI
- 10.1016/j.cell.2007.05.056 · DOI · Paper page
- 10.1261/rna.2780503 · DOI · Paper page
- 10.1126/science.1073827 · DOI · Paper page
- 10.1016/S0076-6879(06)11002-2 · DOI
- 10.1152/physiolgenomics.00144.2007 · DOI · Paper page
- 10.1016/j.cell.2005.07.031 · DOI · Paper page
- 10.1016/j.cell.2009.01.002 · DOI · Paper page
- 10.1161/CIRCRESAHA.108.182535 · DOI · Paper page
- 10.1073/pnas.0608791103 · DOI · Paper page
- 10.1038/nm1582 · DOI · Paper page
- 10.1016/j.cell.2007.03.030 · DOI · Paper page
- 10.1038/nm1569 · DOI · Paper page
- 10.1073/pnas.0805038105 · DOI · Paper page
- 10.1016/j.biocel.2008.02.020 · DOI · Paper page
- 10.1007/s10741-007-9034-1 · DOI · Paper page
- 10.1016/j.tibs.2004.09.002 · DOI
- 10.1073/pnas.0710228105 · DOI · Paper page
- 10.1016/j.biocel.2008.03.002 · DOI
- 10.1161/CIRCULATIONAHA.107.687947 · DOI · Paper page
- 10.1093/cvr/cvn181 · DOI
- 10.1038/ncpcardio1415 · doi:10.1038/ncpcardio1415
- 10.1016/S0733-8651(05)70201-0 · DOI
- 10.1161/CIRCRESAHA.108.181651 · DOI · Paper page
- 10.1152/physrev.1999.79.1.215 · DOI · Paper page
- 10.1152/ajpheart.00151.2005 · DOI
- 10.1111/j.1469-7793.1999.001af.x · DOI · Paper page
- 10.1016/j.febslet.2008.11.014 · DOI
- 10.1093/cvr/cvp015 · DOI · Paper page
- 10.2174/187152509787047676 · DOI
- 10.1126/scisignal.252pe1 · DOI · Paper page
- 10.4161/cc.8.3.7526 · DOI
- 10.1185/030079907X182068 · DOI
- 10.2337/db08-0934 · DOI
- 10.1016/S0167-4889(02)00178-7 · DOI
- 10.1074/jbc.C700015200 · DOI · Paper page
- 10.1002/(SICI)1098-1004(200005)15:5<483::AID-HUMU18>3.0.CO;2-T · doi:10.1002/(sici)1098-1004(200005)15:5<483::aid-humu18>3.0.co;2-t
- 10.1016/j.bbagrm.2008.06.010 · DOI · Paper page
- 10.1210/me.2007-0167 · DOI · Paper page
- 10.1056/NEJM199901143400207 · DOI · Paper page
- 10.1073/pnas.0707493105 · DOI · Paper page
- 10.1161/CIRCRESAHA.106.141986 · DOI · Paper page
- 10.1074/jbc.M701050200 · DOI · Paper page
- 10.1038/ng1253 · DOI · Paper page
- 10.1101/gad.1521307 · DOI · Paper page
- 10.1016/j.cell.2008.02.020 · DOI · Paper page
- 10.1161/CIRCRESAHA.107.153916 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.108.769984 · DOI · Paper page
- 10.1074/jbc.M413394200 · DOI · Paper page
- 10.1161/01.RES.0000265065.26744.17 · DOI · Paper page
- 10.1093/cvr/cvn137 · DOI · Paper page
- 10.1152/physiolgenomics.00206.2007 · DOI
- 10.1038/nature03816 · DOI · Paper page
- 10.1073/pnas.0703037104 · DOI
- 10.1007/s00441-007-0530-3 · DOI · Paper page
- 10.1016/j.cell.2007.11.019 · DOI · Paper page
- 10.1038/nature07040 · DOI · Paper page
- 10.1517/14712598.8.7.911 · DOI
- 10.1182/blood-2006-12-063412 · DOI · Paper page
- 10.1111/j.1582-4934.2008.00615.x · DOI
- 10.1111/j.1582-4934.2005.tb00394.x · doi:10.1111/j.1582-4934.2005.tb00394.x
- 10.1111/j.1582-4934.2008.00668.x · DOI
- 10.1038/35888 · DOI · Paper page
- 10.1016/j.cell.2006.07.031 · DOI · Paper page
- 10.1126/science.1149460 · DOI · Paper page
- 10.1016/j.tig.2008.04.004 · DOI
- 10.1073/pnas.0710558105 · DOI · Paper page
- 10.1038/nmeth1079 · DOI · Paper page
- 10.1038/ng2079 · DOI · Paper page
- 10.1161/CIRCRESAHA.108.183426 · DOI · Paper page
- 10.1161/CIRCRESAHA.108.183087 · DOI · Paper page
- 10.1152/physiol.00037.2006 · DOI
- 10.1161/01.CIR.82.6.2217 · doi:10.1161/01.cir.82.6.2217
- 10.1089/hum.2006.17.193 · doi:10.1089/hum.2006.17.193
- 10.1002/jgm.496 · DOI · Paper page
- 10.1111/j.1538-7836.2006.02220.x · DOI · Paper page
- 10.1038/sj.mt.6300175 · DOI · Paper page
- 10.1007/s12033-007-0010-8 · DOI · Paper page
- 10.1253/circj.70.1503 · DOI
- 10.2174/157488809787169075 · DOI
- 10.1080/10428190802626632 · DOI
- 10.1158/0008-5472.CAN-08-2886 · DOI · Paper page
- 10.1074/jbc.M806920200 · DOI · Paper page
- 10.1016/j.bbrc.2009.01.066 · DOI
- 10.1161/CIRCRESAHA.108.185363 · DOI · Paper page
- 10.1038/sj.onc.1209912 · DOI · Paper page
- 10.1177/107424840200700407 · doi:10.1177/107424840200700407
Cited by
Role for miR-204 in human pulmonary arterial hypertension
Courboulin, A., Paulin, R., Giguère, N. J., Saksouk, N., Perreault, T., Meloche, J., Paquet, E. R., Biardel, S., Provencher, S., Côté, J., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101812 · Cited by 523
Akhtar, N., Rasheed, Z., Ramamurthy, S., Anbazhagan, A. N., Voss, F. R., & Haqqi, T. M. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27329 · Cited by 331
Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development
Maegdefessel, L., Azuma, J., Toh, R., Merk, D. R., Deng, A., Chin, J. T., Raaz, U., Schoelmerich, A. M., Raiesdana, A., Leeper, N. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61598 · Cited by 306
MicroRNA-21 Blocks Abdominal Aortic Aneurysm Development and Nicotine-Augmented Expansion
Maegdefessel, L., Azuma, J., Toh, R., Deng, A., Merk, D. R., Raiesdana, A., Leeper, N. J., Raaz, U., Schoelmerich, A. M., McConnell, M. V., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003441 · Cited by 301
MicroRNAs and the regulation of fibrosis
Jiang, X., Tsitsiou, E., Herrick, S. E., & Lindsay, M. A. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07632.x · Cited by 258
Metadata
- Authors
- Mishra, P. K., Tyagi, N., Kumar, M., & Tyagi, S. C.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2009-04
- Volume
- 13
- Issue
- 4
- Pages
- 778-789
- ISSN
- 1582-1838
- 1582-4934
- Cited by
- 119
- References
- 15
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MicroRNAs as a therapeutic target for cardiovascular diseases. https://app.cochat.ai/papers/10.1111/j.1582-4934.2009.00744.x
- The paper
- Mishra, P. K., Tyagi, N., Kumar, M., & Tyagi, S. C. (2009). MicroRNAs as a therapeutic target for cardiovascular diseases. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2009.00744.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.